Nicholas Allan John Botwood

Title: Innovations in Cancer Treatment by Nicholas Allan John Botwood

Introduction

Nicholas Allan John Botwood is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer treatment, particularly in addressing small cell lung cancer (SCLC). His innovative approaches have the potential to improve patient outcomes and advance therapeutic strategies.

Latest Patents

Nicholas Botwood holds a patent for "Methods of treating tumor." This patent outlines a method for treating subjects afflicted with tumors derived from SCLC that have a high tumor mutational burden (TMB) status. The method involves administering a monotherapy comprising an anti-PD-1 antibody or a combination therapy that includes both an anti-PD-1 antibody and an anti-CTLA-4 antibody. Additionally, the patent describes a method for identifying suitable subjects for this treatment by measuring the TMB status of a biological sample. A high TMB status indicates that the patient is suitable for treatment with the anti-PD-1 antibody or its antigen-binding portion. The TMB status can be determined through sequencing nucleic acids in the tumor and identifying genomic alterations, such as somatic nonsynonymous mutations.

Career Highlights

Nicholas Botwood is currently associated with Bristol-Myers Squibb Company, where he continues to work on innovative cancer therapies. His research focuses on enhancing treatment options for patients with high TMB status, aiming to provide more effective solutions for those battling SCLC.

Collaborations

Nicholas collaborates with esteemed colleagues, including Prabhu Seshaiyer Bhagavatheeswaran and Han Chang. These collaborations foster a dynamic research environment that encourages the exchange of ideas and expertise in cancer treatment.

Conclusion

Nicholas Allan John Botwood's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient care. His work at Bristol-Myers Squibb Company and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.